These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16504840)

  • 1. Hepatitis C infection and diabetes.
    Noto H; Raskin P
    J Diabetes Complications; 2006; 20(2):113-20. PubMed ID: 16504840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes.
    Mihm S
    Dig Dis; 2010; 28(1):280-4. PubMed ID: 20460924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis C virus-associated and metabolic steatosis. Different or overlapping diseases?].
    Lonardo A; Loria P; Adinolfi LE; Andreana A; Ruggiero G; Carulli N
    Ann Ital Med Int; 2005; 20(1):10-22. PubMed ID: 15859390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: hepatitis C virus-associated steatosis--pathogenic mechanisms and clinical implications.
    Adinolfi LE; Durante-Mangoni E; Zampino R; Ruggiero G
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():52-5. PubMed ID: 16225474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
    Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
    Serfaty L; Capeau J
    Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S; Younossi ZM
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steatosis in hepatitis C virus infection. Response to anti-viral therapy.
    Szanto P; Grigorescu M; Dumitru I; Serban A
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):117-24. PubMed ID: 16802005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C and diabetes: the inevitable coincidence?
    Lonardo A; Adinolfi LE; Petta S; Craxì A; Loria P
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):293-308. PubMed ID: 19344243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
    Castera L
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causal relationship between hepatitis C virus core and the development of type 2 diabetes mellitus in a hepatitis C virus hyperendemic area: a pilot study.
    Kawaguchi T; Nagao Y; Tanaka K; Ide T; Harada M; Kumashiro R; Sata M
    Int J Mol Med; 2005 Jul; 16(1):109-14. PubMed ID: 15942686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C and steatosis.
    Björnsson E; Angulo P
    Arch Med Res; 2007 Aug; 38(6):621-7. PubMed ID: 17613353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of steatosis in hepatitis C virus infection.
    Adinolfi LE; Restivo L; Marrone A
    Expert Rev Gastroenterol Hepatol; 2013 Mar; 7(3):205-13. PubMed ID: 23445230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C and diabetes mellitus.
    Banerjee S; Banerjee M
    J Indian Med Assoc; 2006 Feb; 104(2):86-9. PubMed ID: 16856589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus and glucose and lipid metabolism.
    Alaei M; Negro F
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):692-700. PubMed ID: 19195632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH.
    Koike K; Moriya K
    J Gastroenterol; 2005 Apr; 40(4):329-36. PubMed ID: 15868369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current understanding of insulin resistance in hepatitis C.
    Kaddai V; Negro F
    Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):503-16. PubMed ID: 21780897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance, hepatic steatosis and hepatitis C: a complex relationship with relevant clinical implications.
    Arrese M; Riquelme A; Soza A
    Ann Hepatol; 2010; 9 Suppl():112-8. PubMed ID: 20714007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
    Imazeki F; Yokosuka O; Fukai K; Kanda T; Kojima H; Saisho H
    Liver Int; 2008 Mar; 28(3):355-62. PubMed ID: 18290778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.